Not every normotensive PE patient is truly low risk. sPESI helps identify patients who may be safe for outpatient management, while Bova helps recognize patients at risk for early deterioration despite initially stable vital signs.
In patients with intermediate-risk pulmonary embolism (PE), does ultrasound-facilitated, catheter-directed fibrinolysis (US-CDT) plus anticoagulation improve clinical outcomes compared to anticoagulation alone?
Diagnosing PE in the emergency department is tricky. The symptoms—chest pain, shortness of breath, tachycardia—are nonspecific and overlap with many other conditions. But missing a PE can have devastating consequences, so there’s often a low threshold to order a CTA. ...
Background: The mainstay of treatment for symptomatic pulmonary embolism (PE) is anticoagulation (AC). Patients with higher-risk PE may require advanced interventions such as thrombolytic therapy, surgical thrombectomy, or even extracorporeal membrane oxygenation (ECMO). Because of its short half-life and availability ...
Background: Massive pulmonary embolism defined as sustained hypotension (SBP <90mmHg) has a high mortality which is why early recognition and thrombolytic therapy is typically recommended (AHA Class IIA; ESC Class IB) . However, full-dose thrombolytic therapy (Alteplase 100mg (IV) is associated ...
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.
